Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-03-05
1993-05-25
Nutter, Nathan M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A01N 4342, A61K 3144
Patent
active
052140504
ABSTRACT:
Red blood cells which are infected with the parasite P. falciparum cause the cells to become sticky and less deformable. This results in a build-up of cells on the vascular wall and creates occlusions to blood flow which are thought to cause the cerebral, renal and liver complications of P. falciparum infections. Certain esters of castanospermine prevent or reduce the adhesion of falciparum infected blood cells to the vascular endothelial wall and are a useful adjunct in the treatment of malaria.
Bitonti Alan J.
McCann Peter P.
Sjoerdsma Albert
Merrell Dow Pharmaceuticals Inc.
Nutter Nathan M.
Willmann Neal O.
LandOfFree
Esters of castanospermine in the treatment of cerebral malaria does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Esters of castanospermine in the treatment of cerebral malaria, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Esters of castanospermine in the treatment of cerebral malaria will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-897381